Compare OGN & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | CSTM |
|---|---|---|
| Founded | 1923 | 2010 |
| Country | United States | France |
| Employees | N/A | 11500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.5B |
| IPO Year | 2020 | 2012 |
| Metric | OGN | CSTM |
|---|---|---|
| Price | $13.89 | $22.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.33 | ★ $33.52 |
| AVG Volume (30 Days) | ★ 2.3M | 1.6M |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | N/A | ★ 405.26 |
| EPS | 1.56 | ★ 3.31 |
| Revenue | $6,216,000,000.00 | ★ $8,449,000,000.00 |
| Revenue This Year | N/A | $28.19 |
| Revenue Next Year | $2.07 | N/A |
| P/E Ratio | $8.91 | ★ $6.83 |
| Revenue Growth | N/A | ★ 15.19 |
| 52 Week Low | $5.69 | $14.62 |
| 52 Week High | $13.90 | $36.99 |
| Indicator | OGN | CSTM |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | 39.82 |
| Support Level | $13.72 | $22.18 |
| Resistance Level | N/A | $26.96 |
| Average True Range (ATR) | 0.05 | 1.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 90.63 | 35.32 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.